As of May 29, 2025, Luminex Corp (LMNX) reports a Current Ratio of 5.82.
Current Ratio assesses a company's ability to pay short-term debts by comparing liquid assets to liabilities, with higher ratios signaling better financial health.
Historical Trend of Luminex Corp's Current Ratio
Over recent years, Luminex Corp's Current Ratio has shown a moderate pattern. The table below summarizes the historical values:
| Date | Current Ratio |
|---|---|
| 2020-12-31 | 5.82 |
| 2019-12-31 | 3.49 |
| 2018-12-31 | 3.94 |
| 2017-12-31 | 4.97 |
| 2016-12-31 | 4.32 |
This slight upward trend highlights how Luminex Corp manages its short-term assets and liabilities over time.
Comparing Luminex Corp's Current Ratio to Peers
To better understand Luminex Corp's position, it's useful to compare its Current Ratio against industry peers. Below are selected comparisons:
| Company | Current Ratio |
|---|---|
| Luminex Corp (LMNX) | 5.82 |
| Seer Inc (SEER) | 16.53 |
| Quanterix Corp (QTRX) | 8.67 |
| Repligen Corp (RGEN) | 8.41 |
| Immunoprecise Antibodies Ltd (IPA.V) | 8.05 |
| Maravai LifeSciences Holdings Inc (MRVI) | 7.53 |
Compared to its competitors, Luminex Corp's Current Ratio is about average compared to peers, reflecting balanced short-term asset management.